Day Return
YTD Return
1-Year Return
3-Year Return
5-Year Return
Note: Industry performance is calculated based on the previous closing price of all industry constituents
Largest Companies in This Industry
View MoreName | Last Price | 1Y Target Est. | Market Weight | Market Cap | Day Change % | YTD Return | Avg. Analyst Rating |
|---|---|---|---|---|---|---|---|
| | 140.22 | 25.84% | | | | Buy | |
| | 116.20 | 17.26% | | | | Strong Buy | |
| | 423.98 | 16.70% | | | | Buy | |
| | 97.10 | 12.33% | | | | Buy | |
| | 80.40 | 5.07% | | | | Buy | |
| | 97.68 | 3.74% | | | | Strong Buy | |
| | 251.36 | 2.72% | | | | Buy | |
| | 323.70 | 2.52% | | | | Buy | |
| | 108.62 | 2.15% | | | | Hold | |
| | 318.59 | 1.18% | | | | Buy |
Investing in the Medical Devices Industry
Start Investing in Medical Devices Through These Companies
Top Performing Companies
View MoreName | Last Price | 1Y Target Est. | YTD Return |
|---|---|---|---|
| | - | | |
| | - | | |
| | 124.43 | | |
| | 15.00 | | |
| | 6.73 | |
High Growth Companies
View MoreName | Last Price | Growth Estimate | YTD Return |
|---|---|---|---|
| | | | |
| | | | |
| | | | |
| | | | |
| | | |
Medical Devices Research
View MoreDiscover the Latest Analyst and Technical Research for This Industry
Daily – Vickers Top Insider Picks for 05/15/2025
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 05/14/2025
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
CTKB: Lowering target price to $2.00
CYTEK BIOSCIENCES INC has an Investment Rating of SELL; a target price of $2.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
RatingPrice TargetGKOS: Raising target price to $97.00
GLAUKOS CORP has an Investment Rating of HOLD; a target price of $97.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice Target